THE AIM OF THE IOT PROJECT IS TO DEFINE A NEW MANAGEMENT MODEL FOR CHRONIC CANCER SUFFERERS, THROUGH THE DEVELOPMENT AND TESTING OF ADVANCED TECHNOLOGY SYSTEMS (INTEGRATED WEB-BASED PLATFORM, DRUG CONTROL DISPENSERS, ECG, THE ENDOTHELIAL DYSFUNCTION OF THE UNITED KINGDOM TO A BASIC TECHNOLOGY KIT) THAT ALLOW THE PATIENT TO BE HANDLED AT HOME BY MEANS OF A CONTROL CENTRE GOVERNED BY A QUALIFIED INSPECTION CENTRE. THIS PROJECT PROPOSAL INVOLVES 10 SMES, A LARGE COMPANY, TWO INVESTIGATORS. 200 USERS ARE INVOLVED IN THE TRIAL PLAN UNDER THE SUPERVISION OF ASUR2 FOR 24 MONTHS CARRIED OUT WITH THE COLLABORATION OF THE ONCOLOGY ASSOCIATIONS OF SENIGALLIA AND FABRIANO. THE PROJECT HAS HAD THE AMBITION TO BUILD A MIXED PUBLIC PRIVATE MODEL THAT ALSO INVOLVES THIRD SECTOR ASSOCIATIONS OPENING IMPORTANT COOPERATION SCENARIOS. THE MAIN COMPETITIVE ADVANTAGE EXPECTED FROM THESE COMPANIES IS THOSE OF ARRIVAR.